SCHEMBL17290632

SCHEMBL17290632

CO/N=C(\C)c1c(C(C)(C)C)nn(-c2ccccc2)c1O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RIPK2 O43353 4/20 0.39
▸ ATM Q13315 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ GRN P28799 1/20 0.35
▸ SORT1 Q99523 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ MAPK13 O15264 3/20 0.33
▸ MAPK12 P53778 3/20 0.33
▸ MAPK11 Q15759 3/20 0.33
▸ MAPK14 Q16539 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ MPO P05164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17290634 1.00 RIPK2 (0.39) RIPK2ATMLMNAALDH1A1GRN
SCHEMBL14886976 0.82 HPGD (0.47) ALDH1A1HPGDKDM4EPOLBHSD17B10
SCHEMBL14886978 0.82 HPGD (0.47) ALDH1A1HPGDKDM4EPOLBHSD17B10
SCHEMBL17290315 0.81 RAB9A (0.43) ATMLMNAALDH1A1MEN1KMT2A
SCHEMBL17290317 0.81 RAB9A (0.43) ATMLMNAALDH1A1MEN1KMT2A
SCHEMBL17290730 0.79 ALDH1A1 (0.46) RIPK2ATMALDH1A1GRNSORT1
SCHEMBL17290468 0.79 LMNA (0.36) LMNAALDH1A1MEN1KMT2AMAPK13
SCHEMBL17290466 0.79 LMNA (0.36) LMNAALDH1A1MEN1KMT2AMAPK13
SCHEMBL17290674 0.77 LMNA (0.41) LMNAALDH1A1KDM4E
SCHEMBL17290672 0.77 LMNA (0.41) LMNAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 — — US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 — — EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 — — WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 RIPK2 1661/4885ATM 1203/4885LMNA 2480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback